Report cover image

Global Gliquidone Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

Publisher APO Research, Inc.
Published Oct 20, 2025
Length 182 Pages
SKU # APRC20553292

Description

Summary

According to APO Research, The global Gliquidone market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Gliquidone is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Gliquidone is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Gliquidone is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Gliquidone is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Gliquidone include Boehringer Ingelheim, Dexa Medica, Menarini Belgium, CR Double-Crane, Jinheng Pharma, Vanguard Pharma, Yiling Pharma and TIPR, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Gliquidone, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Gliquidone, also provides the sales of main regions and countries. Of the upcoming market potential for Gliquidone, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Gliquidone sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Gliquidone market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Gliquidone sales, projected growth trends, production technology, application and end-user industry.

Gliquidone Segment by Company

Boehringer Ingelheim
Dexa Medica
Menarini Belgium
CR Double-Crane
Jinheng Pharma
Vanguard Pharma
Yiling Pharma
TIPR
Gliquidone Segment by Type

Glequinone Tablets
Glequinone Capsule
Glequinone Sustained Release Tablets
Others
Gliquidone Segment by Application

Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
Gliquidone Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gliquidone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Gliquidone and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gliquidone.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Gliquidone market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gliquidone manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Gliquidone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Gliquidone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

182 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Gliquidone Market Size, 2020 VS 2024 VS 2031
1.3 Global Gliquidone Market Size Estimates and Forecasts (2020-2031)
1.4 Global Gliquidone Sales Estimates and Forecasts (2020-2031)
1.5 Global Gliquidone Market Average Price (2020-2031)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 Global Gliquidone Market Dynamics
2.1 Gliquidone Industry Trends
2.2 Gliquidone Industry Drivers
2.3 Gliquidone Industry Opportunities and Challenges
2.4 Gliquidone Industry Restraints
3 Gliquidone Market by Manufacturers
3.1 Global Gliquidone Revenue by Manufacturers (2020-2025)
3.2 Global Gliquidone Sales by Manufacturers (2020-2025)
3.3 Global Gliquidone Average Sales Price by Manufacturers (2020-2025)
3.4 Global Gliquidone Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
3.5 Global Gliquidone Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Gliquidone Manufacturers, Product Type & Application
3.7 Global Gliquidone Manufacturers Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Gliquidone Market CR5 and HHI
3.8.2 Global Top 5 and 10 Gliquidone Players Market Share by Revenue in 2024
3.8.3 2024 Gliquidone Tier 1, Tier 2, and Tier 3
4 Gliquidone Market by Type
4.1 Gliquidone Type Introduction
4.1.1 Glequinone Tablets
4.1.2 Glequinone Capsule
4.1.3 Glequinone Sustained Release Tablets
4.1.4 Others
4.2 Global Gliquidone Sales by Type
4.2.1 Global Gliquidone Sales by Type (2020 VS 2024 VS 2031)
4.2.2 Global Gliquidone Sales by Type (2020-2031)
4.2.3 Global Gliquidone Sales Market Share by Type (2020-2031)
4.3 Global Gliquidone Revenue by Type
4.3.1 Global Gliquidone Revenue by Type (2020 VS 2024 VS 2031)
4.3.2 Global Gliquidone Revenue by Type (2020-2031)
4.3.3 Global Gliquidone Revenue Market Share by Type (2020-2031)
5 Gliquidone Market by Application
5.1 Gliquidone Application Introduction
5.1.1 Hospital Pharmacies
5.1.2 Online Pharmacies
5.1.3 Retail Pharmacies
5.2 Global Gliquidone Sales by Application
5.2.1 Global Gliquidone Sales by Application (2020 VS 2024 VS 2031)
5.2.2 Global Gliquidone Sales by Application (2020-2031)
5.2.3 Global Gliquidone Sales Market Share by Application (2020-2031)
5.3 Global Gliquidone Revenue by Application
5.3.1 Global Gliquidone Revenue by Application (2020 VS 2024 VS 2031)
5.3.2 Global Gliquidone Revenue by Application (2020-2031)
5.3.3 Global Gliquidone Revenue Market Share by Application (2020-2031)
6 Global Gliquidone Sales by Region
6.1 Global Gliquidone Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Gliquidone Sales by Region (2020-2031)
6.2.1 Global Gliquidone Sales by Region (2020-2025)
6.2.2 Global Gliquidone Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Gliquidone Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.3.2 North America Gliquidone Sales by Country (2020-2031)
6.3.3 U.S.
6.3.4 Canada
6.3.5 Mexico
6.4 Europe
6.4.1 Europe Gliquidone Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.4.2 Europe Gliquidone Sales by Country (2020-2031)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Gliquidone Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.5.2 Asia Pacific Gliquidone Sales by Country (2020-2031)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 South America, Middle East and Africa
6.6.1 South America, Middle East and Africa Gliquidone Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.6.2 South America, Middle East and Africa Gliquidone Sales by Country (2020-2031)
6.6.3 Brazil
6.6.4 South Africa
6.6.5 Saudi Arabia
6.6.6 Turkey
6.6.6 Argentina
6.6.6 UAE
6.6.6 Egypt
6.6.6 Chile
7 Global Gliquidone Revenue by Region
7.1 Global Gliquidone Revenue by Region
7.1.1 Global Gliquidone Revenue by Region: 2020 VS 2024 VS 2031
7.1.2 Global Gliquidone Revenue by Region (2020-2025)
7.1.3 Global Gliquidone Revenue by Region (2026-2031)
7.1.4 Global Gliquidone Revenue Market Share by Region (2020-2031)
7.2 North America
7.2.1 North America Gliquidone Revenue (2020-2031)
7.2.2 North America Gliquidone Revenue Share by Country: 2020 VS 2024 VS 2031
7.3 Europe
7.3.1 Europe Gliquidone Revenue (2020-2031)
7.3.2 Europe Gliquidone Revenue Share by Country: 2020 VS 2024 VS 2031
7.4 Asia-Pacific
7.4.1 Asia-Pacific Gliquidone Revenue (2020-2031)
7.4.2 Asia-Pacific Gliquidone Revenue Share by Country: 2020 VS 2024 VS 2031
7.5 South America, Middle East and Africa
7.5.1 South America, Middle East and Africa Gliquidone Revenue (2020-2031)
7.5.2 South America, Middle East and Africa Gliquidone Revenue Share by Country: 2020 VS 2024 VS 2031
8 Company Profiles
8.1 Boehringer Ingelheim
8.1.1 Boehringer Ingelheim Comapny Information
8.1.2 Boehringer Ingelheim Business Overview
8.1.3 Boehringer Ingelheim Gliquidone Sales, Price, Revenue and Gross Margin (2020-2025)
8.1.4 Boehringer Ingelheim Gliquidone Product Portfolio
8.1.5 Boehringer Ingelheim Recent Developments
8.2 Dexa Medica
8.2.1 Dexa Medica Comapny Information
8.2.2 Dexa Medica Business Overview
8.2.3 Dexa Medica Gliquidone Sales, Price, Revenue and Gross Margin (2020-2025)
8.2.4 Dexa Medica Gliquidone Product Portfolio
8.2.5 Dexa Medica Recent Developments
8.3 Menarini Belgium
8.3.1 Menarini Belgium Comapny Information
8.3.2 Menarini Belgium Business Overview
8.3.3 Menarini Belgium Gliquidone Sales, Price, Revenue and Gross Margin (2020-2025)
8.3.4 Menarini Belgium Gliquidone Product Portfolio
8.3.5 Menarini Belgium Recent Developments
8.4 CR Double-Crane
8.4.1 CR Double-Crane Comapny Information
8.4.2 CR Double-Crane Business Overview
8.4.3 CR Double-Crane Gliquidone Sales, Price, Revenue and Gross Margin (2020-2025)
8.4.4 CR Double-Crane Gliquidone Product Portfolio
8.4.5 CR Double-Crane Recent Developments
8.5 Jinheng Pharma
8.5.1 Jinheng Pharma Comapny Information
8.5.2 Jinheng Pharma Business Overview
8.5.3 Jinheng Pharma Gliquidone Sales, Price, Revenue and Gross Margin (2020-2025)
8.5.4 Jinheng Pharma Gliquidone Product Portfolio
8.5.5 Jinheng Pharma Recent Developments
8.6 Vanguard Pharma
8.6.1 Vanguard Pharma Comapny Information
8.6.2 Vanguard Pharma Business Overview
8.6.3 Vanguard Pharma Gliquidone Sales, Price, Revenue and Gross Margin (2020-2025)
8.6.4 Vanguard Pharma Gliquidone Product Portfolio
8.6.5 Vanguard Pharma Recent Developments
8.7 Yiling Pharma
8.7.1 Yiling Pharma Comapny Information
8.7.2 Yiling Pharma Business Overview
8.7.3 Yiling Pharma Gliquidone Sales, Price, Revenue and Gross Margin (2020-2025)
8.7.4 Yiling Pharma Gliquidone Product Portfolio
8.7.5 Yiling Pharma Recent Developments
8.8 TIPR
8.8.1 TIPR Comapny Information
8.8.2 TIPR Business Overview
8.8.3 TIPR Gliquidone Sales, Price, Revenue and Gross Margin (2020-2025)
8.8.4 TIPR Gliquidone Product Portfolio
8.8.5 TIPR Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Gliquidone Value Chain Analysis
9.1.1 Gliquidone Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Gliquidone Production Mode & Process
9.2 Gliquidone Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Gliquidone Distributors
9.2.3 Gliquidone Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.